SK
Suma Kantipudi
About Suma Kantipudi
Data last updated:
Suma Kantipudi is a Director at Natco Pharma Limited (since 2024), Director at Prasad Hospitals India Private Limited (since 2010) and Director at Blue Gene Private Limited (since 2010), and holds 4 more current directorships. The companies operate in Agriculture, Healthcare and Infrastructure and Utilities. The 7 current companies with reported revenue have a combined latest revenue of ₹4,865 Cr; the largest is Natco Pharma Limited at ₹4,784 Cr (FY 2025). Earlier, Suma Kantipudi was a Director at Pathcare Labs Private Limited (2011–2015).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Natco Pharma Limited L24230TG1981PLC003201 | Director | 12 Aug 2024 | 1981 | ₹4,784 Cr (FY 2025) | Active |
 Prasad Hospitals India Private Limited U85100TG2010PTC067167 | Director | 23 Feb 2010 | 2010 | ₹76.44 Cr (FY 2025) | Active |
 Blue Gene Private Limited U85100TG2010PTC067176 | Director | 23 Feb 2010 | 2010 | ₹2.13 Cr (FY 2025) | Active |
 Prasad Property Management Private Limited U45209TG2022PTC161425 | Director | 09 Apr 2022 | 2022 | ₹1.15 Cr (FY 2025) | Active |
| Hsrl Enterprises Private Limited U45309TG2019PTC133729 | Director | 27 Jun 2019 | 2019 | ₹1.13 Cr (FY 2025) | Active |
 Melite Soft Technologies Private Limited U72300TG2015PTC099846 | Director | 20 Jul 2015 | 2015 | ₹65.3 Lakh (FY 2020) | Active |
| Prasad Research Foundation U85300TG2017NPL117453 | Director | 30 May 2017 | 2017 | ₹1,000 (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Pathcare Labs Private Limited U85195TG2007PTC055747 | Director | 01 Apr 2011 | 2007 | ₹124 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Suma Kantipudi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suma Kantipudi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suma Kantipudi
Suma Kantipudi currently holds 7 directorships: Natco Pharma Limited (Director, since 12 Aug 2024, revenue ₹4,784 Cr (FY 2025)); Prasad Hospitals India Private Limited (Director, since 23 Feb 2010, revenue ₹76.44 Cr (FY 2025)); Blue Gene Private Limited (Director, since 23 Feb 2010, revenue ₹2.13 Cr (FY 2025)); Prasad Property Management Private Limited (Director, since 09 Apr 2022, revenue ₹1.15 Cr (FY 2025)); Hsrl Enterprises Private Limited (Director, since 27 Jun 2019, revenue ₹1.13 Cr (FY 2025)); and 2 more.
Suma Kantipudi was first appointed on 23 Feb 2010 as Director at Prasad Hospitals India Private Limited. The most recent appointment on record is 12 Aug 2024 at Natco Pharma Limited.
The 7 current companies of Suma Kantipudi that report revenue have a combined latest revenue of ₹4,865 Cr: Natco Pharma Limited ₹4,784 Cr (FY 2025); Prasad Hospitals India Private Limited ₹76.44 Cr (FY 2025); Blue Gene Private Limited ₹2.13 Cr (FY 2025); Prasad Property Management Private Limited ₹1.15 Cr (FY 2025); Hsrl Enterprises Private Limited ₹1.13 Cr (FY 2025); and 2 more.
Suma Kantipudi held 1 earlier board appointment: Pathcare Labs Private Limited (Director, 01 Apr 2011 to 29 Dec 2015).
The current boards of Suma Kantipudi's companies include Agnihotra Dakshina Murty Chavali (Natco Pharma Limited), Amit Parekh (Natco Pharma Limited), Lakshminarayana Bolisetty (Natco Pharma Limited), Lingarao Donthineni (Natco Pharma Limited), Nitin Jain (Natco Pharma Limited), Potluri Prasad Sivaramakrishna (Natco Pharma Limited), among others.